These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3014839)

  • 1. PRPP synthetase superactivity in lymphoblast lines.
    Becker MA; Losman MJ; Rimon D; Kim M
    Adv Exp Med Biol; 1986; 195 Pt A():51-8. PubMed ID: 3014839
    [No Abstract]   [Full Text] [Related]  

  • 2. Inherited phosphoribosylpyrophosphate synthetase superactivity due to aberrant inhibitor and activator responsiveness.
    Becker MA; Losman MJ; Simmonds HA
    Adv Exp Med Biol; 1986; 195 Pt A():59-66. PubMed ID: 3014841
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurodevelopmental impairment and deranged PRPP and purine nucleotide synthesis in inherited superactivity of PRPP synthetase.
    Becker MA; Puig JG; Mateos FA; Jimenez ML; Kim M; Simmonds HA
    Adv Exp Med Biol; 1989; 253A():15-22. PubMed ID: 2483028
    [No Abstract]   [Full Text] [Related]  

  • 4. Phosphoribosylpyrophosphate synthetase superactivity: detection, characterization of underlying defects, and treatment.
    Becker MA
    Adv Exp Med Biol; 1984; 165 Pt A():91-96. PubMed ID: 6326492
    [No Abstract]   [Full Text] [Related]  

  • 5. Kinetic aspects of purine metabolism in cultured fibroblasts. A comparative study of cells from patients overproducing purines due to HGPRT deficiency and PRPP synthetase superactivity.
    Zoref E; de Vries A; Sperling O
    Monogr Hum Genet; 1978; 10():96-9. PubMed ID: 214700
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased purine nucleotide degradation in the central nervous system (CNS) in PRPP synthetase superactivity.
    Jiménez ML; Puig JG; Mateos FA; Ramos TH; Melián JS; Nieto VG; Becker MA
    Adv Exp Med Biol; 1989; 253A():9-13. PubMed ID: 2560341
    [No Abstract]   [Full Text] [Related]  

  • 7. [PRPP synthetase superactivity].
    Fujimori S
    Nihon Rinsho; 1996 Dec; 54(12):3309-14. PubMed ID: 8976111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superactivity of human phosphoribosyl pyrophosphate synthetase due to altered regulation by nucleotide inhibitors and inorganic phosphate.
    Becker MA; Losman MJ; Wilson J; Simmonds HA
    Biochim Biophys Acta; 1986 Jun; 882(2):168-76. PubMed ID: 2423135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal purine and pyrimidine metabolism in inherited superactivity of PRPP synthetase.
    Bory C; Chantin C; Boulieu R
    Adv Exp Med Biol; 1994; 370():15-8. PubMed ID: 7660879
    [No Abstract]   [Full Text] [Related]  

  • 10. NAD synthesis by erythrocytes in phosphoribosylpyrophosphate synthetase (PRPPs) superactivity.
    Micheli V; Simmonds HA
    Adv Exp Med Biol; 1989; 253A():1-7. PubMed ID: 2560329
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective expression of phosphoribosylpyrophosphate synthetase superactivity in human lymphoblast lines.
    Losman MJ; Rimon D; Kim M; Becker MA
    J Clin Invest; 1985 Oct; 76(4):1657-64. PubMed ID: 2414323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superactive phosphoribosylpyrophosphate synthetase with altered regulatory and catalytic properties.
    Becker MA; Raivio KO; Bakay B; Adams WB; Nyhan WL
    Adv Exp Med Biol; 1980; 122A():387-92. PubMed ID: 6158850
    [No Abstract]   [Full Text] [Related]  

  • 13. Gout with superactive phosphoribosylpyrophosphate synthetase due to increased enzyme catalytic rate.
    Becker MA; Losman MJ; Itkin P; Simkin PA
    J Lab Clin Med; 1982 Apr; 99(4):495-511. PubMed ID: 6174658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphoribosylpyrophosphate synthetase superactivity. A study of five patients with catalytic defects in the enzyme.
    Becker MA; Losman MJ; Rosenberg AL; Mehlman I; Levinson DJ; Holmes EW
    Arthritis Rheum; 1986 Jul; 29(7):880-8. PubMed ID: 3017368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRPP and purine nucleotide metabolism in human lymphoblasts with both PRPP synthetase superactivity and HGPRT deficiency.
    Becker MA; Kim M; Husain K
    Adv Exp Med Biol; 1989; 253B():13-20. PubMed ID: 2481968
    [No Abstract]   [Full Text] [Related]  

  • 16. Mutant feedback-resistant phosphoribosylpyrophosphate synthetase associated with purine overproduction and gout. Phosphoribosylpyrophosphate and purine metabolism in cultured fibroblasts.
    Zoref E; De Vries A; Sperling O
    J Clin Invest; 1975 Nov; 56(5):1093-9. PubMed ID: 171280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in purine metabolism in cultured fibroblasts with HGPRT deficiency and with PRPP synthetase superactivity.
    Zoref-Shani E; Sperling O
    Adv Exp Med Biol; 1979; 122B():19-24. PubMed ID: 232629
    [No Abstract]   [Full Text] [Related]  

  • 18. Possible metabolic basis for GTP depletion in red cells of patients with PRPP synthetase superactivity.
    Giacomello A; Salerno C
    Adv Exp Med Biol; 1991; 309B():253-6. PubMed ID: 1664182
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence of a new type of phosphoribosylpyrophosphate synthetase with abnormal kinetic properties in hyperuricemias.
    Mousson B; Baltassat P
    Adv Exp Med Biol; 1984; 165 Pt B():1-4. PubMed ID: 6326493
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of accelerated purine nucleotide synthesis in human fibroblasts with superactive phosphoribosylpyrophosphate synthetases.
    Becker MA; Losman MJ; Kim M
    J Biol Chem; 1987 Apr; 262(12):5596-602. PubMed ID: 3032938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.